Ms Carole Ann Al-din, MSSW | |
53 14th St, Ste 600, Wheeling, WV 26003-3423 | |
(304) 232-7294 | |
Not Available |
Full Name | Ms Carole Ann Al-din |
---|---|
Gender | Female |
Speciality | Clinical Social Worker |
Experience | 39 Years |
Location | 53 14th St, Wheeling, West Virginia |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1043388416 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
101YA0400X | Counselor - Addiction (substance Use Disorder) | (West Virginia) | Secondary |
1041C0700X | Social Worker - Clinical | DP00816756 (West Virginia) | Primary |
Mailing Address | Practice Location Address |
---|---|
Ms Carole Ann Al-din, MSSW Po Box 6230, Wheeling, WV 26003 Ph: (304) 242-7106 | Ms Carole Ann Al-din, MSSW 53 14th St, Ste 600, Wheeling, WV 26003-3423 Ph: (304) 232-7294 |
News Archive
In a methodological tour-de-force study, a large group of researchers from the USA and the United Kingdom analyzed patient transcriptomic data in-depth and discovered a circulating microRNA (miR-2392) that is directly implicated in the severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) machinery during the infection process.
MGB Biopharma, a biopharmaceutical company developing a truly novel class of anti-infectives, to address the major global problem of antibiotic resistance today announces that the first group of healthy male volunteers have been dosed in a Phase I clinical trial assessing the safety and tolerability of an oral formulation of MGB-BP-3, for use in the treatment of Clostridium difficile infections.
In a Huffington Post opinion piece, Kolleen Bouchane, director of ACTION, asks whether President Barack Obama will "heed Archbishop [Desmond] Tutu's call to action" in a recent Washington Post opinion piece "and do his part to end AIDS."
Zimmer Holdings, Inc., a global leader in musculoskeletal care, today announced that its Board of Directors has approved the payment of a quarterly cash dividend to stockholders for the first quarter of 2012.
› Verified 7 days ago